Panadea Diagnostics is a science-driven biotech company in a strong partnership with the Bernhard Nocht Institute for Tropical Medicine. We focus on developing and manufacturing top-quality serological tests for tropical and emerging infectious diseases. Leveraging our patented technology platform, our immunoassay tests have superior specificity and sensitivity, especially targeting the priority diseases in the WHO blueprint list.